Pancreatic adenocarcinoma.

Eur Radiol 2007 Mar 5;17(3):638-49. Epub 2006 Oct 5.

Department of Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Adenocarcinoma is the most common malignant pancreatic tumor, affecting the head of the pancreas in 60-70% of cases. By the time of diagnosis, at least 80% of tumors are unresectable. Helical computed tomography (CT) is very effective in detecting and staging adenocarcinoma, with a sensitivity of up to 90% for detection and an accuracy of 80-90% for staging, but it has limitations in detecting small cancers. Moreover, it is not very accurate for determining nonresectability because small liver metastases, peritoneal carcinomatosis, and subtle signs of vascular infiltration may be missed. Multidetector-row CT (MDCT) has brought substantial improvements with its inherent ability to visualize vascular involvement in three dimensions. MDCT has been found to be at least equivalent to contrast-enhanced magnetic resonance imaging (MRI) for detecting adenocarcinoma. MRI can be used as a problem-solving tool in equivocal CT: MRI may help rule out pitfalls, such as inflammatory pseudotumor, focal lipomatosis, abscess, or cystic tumors. Mangafodipir-enhanced MRI reveals a very high tumor-pancreas contrast, which helps in diagnosing small cancers. Endosonography is, if available, also a very accurate tool for detecting small cancers, with a sensitivity of up to 98%. It is the technique of choice for image-guided biopsy if a histologic diagnosis is required for further therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-006-0435-7DOI Listing
March 2007
3 Reads

Publication Analysis

Top Keywords

small cancers
12
detecting small
8
contrast-enhanced magnetic
4
equivalent contrast-enhanced
4
mdct equivalent
4
involvement three
4
three dimensions
4
dimensions mdct
4
magnetic resonance
4
resonance imaging
4
adenocarcinoma mri
4
mri problem-solving
4
problem-solving tool
4
detecting adenocarcinoma
4
mri detecting
4
mri
4
imaging mri
4
vascular involvement
4
ability visualize
4
signs vascular
4

References

(Supplied by CrossRef)

DM Parkin et al.
Int J Cancer 1994

AB Lowenfels et al.
New Engl J Med 1993

AB Lowenfels et al.
J Natl Cancer Inst 1997

N Alexakis et al.
Br J Surg 2004

M Trede et al.
Ann Surg 1990

AL Warshaw et al.
Arch Surg 1990

AL Warshaw et al.
N Engl J Med 1992

GG Tsiotos et al.
World J Surg 1999

KT Tran et al.
Ann Surg 2004

A DelMaschio et al.
Radiology 1991

GM Richter et al.
Radiologe 1998

Similar Publications